ASP3325: Clinical Trials

2 trials of ASP3325, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow ASP3325: new trials by email Literature Review of ASP3325 trials Research Report on ASP3325

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan
ASP3325 - Chronic Kidney Disease, Hyperphosphatemia Undergoing Hemodialysis
Phase 1CompletedAstellas Pharma Inc242014-05-122024-11-05
A Single and Multiple Oral Dose Study and a Treatment Schedule-finding Study in Non-elderly, Healthy Subjects
ASP3325, Placebo - Pharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male Subjects
Phase 1CompletedAstellas Pharma Inc1242013-07-012015-07-17

Conditions studied

Hyperphosphatemia (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

Astellas Pharma Inc (2)

Countries

Japan (2)